| Literature DB >> 34327227 |
Wei Liu1, Xiao Jin2, Zhiqiang Guan3, Qiyun Zhou1.
Abstract
BACKGROUND: Postoperative pain, dysfunction, and significant bone loss may occur after vertebral fractures, which will lead to the occurrence of refractures and shorten the survival time, so postoperative rehabilitation is very important. Pulsed electromagnetic field therapy is noninvasive, pain-relieving, and beneficial to reduce bone loss and is an important treatment for patients to recover after surgery. Therefore, this study analyzed the effect of postmenopausal women's vertebral fracture rehabilitation after pulsed electromagnetic field treatment.Entities:
Mesh:
Year: 2021 PMID: 34327227 PMCID: PMC8302368 DOI: 10.1155/2021/4650057
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographic characteristics of the participants.
|
| PEMF | Control |
|
|---|---|---|---|
| 40 | 42 | ||
| Age, years, mean (SD) | 61.5 (2.1) | 63.5 (1.2) | 0.85 |
| Height, mean (SD), cm | 152.61 (1.9) | 154.62 (2.8) | 0.45 |
| BMI, mean (SD), kg/m2 | 23.5 (2.9) | 23.4 (1.4) | 0.25 |
| Body weight, mean (SD), kg | 61.5 (3.8) | 62.3 (4.5) | 0.31 |
| Lumbar spine BMD, g/cm2, mean ± SD | 0.624 (0.0152) | 0.694 (0.151) | 0.25 |
| Total hip BMD, g/cm2, mean ± SD | 0.534 (0.021) | 0.554 (0.015) | 0.21 |
|
| &-2.8 (0.4) | &-2.4 (0.1) | 0.09 |
|
| &-3.8 (0.2) | &-3.9 (0.3) | 0.24 |
PEMF: pulsed electromagnetic field treatment group; BMI: body mass index; BMD: bone mineral density, P values derived from mixed-effect models for longitudinal percent change from baseline with a fixed effect for treatment groups, time and adjustments for baseline measurements in an intention-to-treat analysis.
Effect of pulsed electromagnetic fields (PEMFs) on pain and function.
| Baseline | 1 month | 3 months | |||||||
|---|---|---|---|---|---|---|---|---|---|
| PEMF | Control |
| PEMF | Control |
| PEMF | Control |
| |
| Lumbar back pain VAS | 7.35 ± 1.25 | 7.54 ± 0.95 | 0.51 | 3.68 ± 0.94 | 4.02 ± 0.61 | 0.09 | 3.05 ± 0.36 | 3.91 ± 0.48 | 0.02 |
| ECOS-16 | 2.51 ± 0.52 | 2.45 ± 0.25 | 0.63 | 2.32 ± 0.35 | 2.38 ± 0.61 | 0.25 | 2.12 ± 0.31 | 2.42 ± 0.63 | 0.01 |
| Physical function score | 1.84 ± 0.84 | 1.86 ± 0.25 | 0.58 | 1.51 ± 0.62 | 1.89 ± 0.21 | 0.02 | 1.41 ± 0.25 | 1.86 ± 0.61 | 0.01 |
| Psychosocial score | 2.58 ± 0.25 | 2.84 ± 0.64 | 0.65 | 1.25 ± 0.61 | 2.42 ± 0.67 | 0.01 | 1.36 ± 0.64 | 2.22 ± 0.12 | 0.01 |
| EuroQoL VAS | 60.31 ± 10.25 | 63.15 ± 9.25 | 0.89 | 73.61 ± 11.62 | 68.25 ± 12.02 | 0.59 | 82.61 ± 13.64 | 69.36 ± 15.64 | 0.04 |
| 6-MWT | 384.61 ± 23.61 | 381.25 ± 6.58 | 0.09 | 415.61 ± 15.26 | 385.61 ± 15.64 | 0.03 | 446.38 ± 23.61 | 395.15 ± 24.61 | 0.01 |
| Chair Sit-and-Reach right | 90.15 ± 8.61 | 89.61 ± 3.61 | 0.58 | 93.61 ± 4.52 | 87.61 ± 6.61 | 0.02 | 98.64 ± 3.61 | 88.68 ± 5.93 | 0.01 |
| Chair Sit-and-Reach left | 85.68 ± 5.97 | 88.94 ± 6.35 | 0.55 | 94.81 ± 6.94 | 89.64 ± 2.98 | 0.04 | 96.68 ± 5.21 | 89.61 ± 5.94 | 0.02 |
| Radiographic fusion rate | N/A | N/A | N/A | 83.6 ± 1.25 | 80.61 ± 2.61 | 0.35 | 86.91 ± 3.1 | 81.61 ± 5.6 | 0.01 |
PEMF: pulsed electromagnetic field treatment group; VAS: visual analog scale/score; ECOS-16: osteoporosis quality of life scoring scale-16; 6-MWT: 6-minute walk test; N/A: not applicable, P values derived from mixed-effect models for longitudinal percent change from baseline with a fixed effect for treatment groups, time and adjustments for baseline measurements in an intention-to-treat analysis.
Effect of PEMF on bone mineral density.
| PEMF | Control |
| |
|---|---|---|---|
| Total hip BMD (g/cm2) | |||
| 1 month | 0.692 (0.025) | 0.688 (0.089) | 0.36 |
| 3 months | 0.731 (0.042) | 0.611 (0.025) | 0.06 |
PEMF: pulsed electromagnetic field treatment group; BMD: bone mineral density, P values derived from mixed-effect models for longitudinal percent change from baseline with a fixed effect for treatment groups, time and adjustments for baseline measurements in an intention-to-treat analysis.
Figure 1PEMF improves the bone microstructure in the tibia and radius.
Effect of pulsed electromagnetic fields (PEMF) on bone microstructure.
| Baseline | 1 month | 3 months | |||||||
|---|---|---|---|---|---|---|---|---|---|
| PEMF | Control |
| PEMF | Control |
| PEMF | Control |
| |
| Radius | |||||||||
| Total vBMD (g/cm3) | 193 (3) | 198 (1) | 0.81 | 198 (2) | 198 (1) | 0.25 | 203 (2) | 193 (2) | 0.02 |
| Cortical thickness (mm) | 0.43 (0.14) | 0.41 (0.13) | 0.26 | 0.49 (0.02) | 0.43 (0.03) | 0.25 | 0.54 (0.03) | 0.40 (0.02) | 0.01 |
| BV/TV (%) | 7.26 (0.32) | 7.35 (0.22) | 0.61 | 7.29 (0.35) | 7.01 (0.23) | 0.21 | 7.33 (0.12) | 7.00 (0.53) | 0.02 |
| Trabecular.N (mm−1) | 1.21 (0.15) | 1.23 (0.11) | 0.48 | 1.35 (0.16) | 1.30 (0.21) | 0.58 | 1.45 (0.25) | 1.31 (0.35) | 0.01 |
| Trabecular thickness (mm) | 0.072 (0.0003) | 0.075 (0.0018) | 0.52 | 0.073 (0.0014) | 0.061 (0.0024) | 0.04 | 0.075 (0.0036) | 0.063 (0.0025) | 0.02 |
| Tibia | |||||||||
| Total vBMD (g/cm3) | 181 (3) | 180 (1) | 0.36 | 161 (2) | 150 (3) | 0.04 | 173 (2) | 153 (3) | 0.02 |
| Cortical thickness (mm) | 0.59 (0.052) | 0.58 (0.024) | 0.52 | 0.51 (0.021) | 0.50 (0.015) | 0.58 | 0.55 (0.034) | 0.48 (0.0024) | 0.02 |
| BV/TV (%) | 9.36 (0.14) | 9.56 (0.85) | 0.32 | 9.84 (0.54) | 9.25 (0.94) | 0.01 | 9.88 (0.35) | 9.02 (0.69) | 0.01 |
| Trabecular.N (mm−1) | 1.35 (0.03) | 1.33 (0.02) | 0.48 | 1.42 (0.01) | 1.30 (0.05) | 0.25 | 1.45 (0.05) | 1.25 (0.08) | 0.01 |
| Trabecular thickness (mm) | 0.067 (0.0015) | 0.068 (0.0034) | 0.28 | 0.072 (0.0025) | 0.061 (0.0025) | 0.02 | 0.075 (0.0021) | 0.063 (0.0024) | 0.02 |
PEMF: pulsed electromagnetic field treatment group; BMD: bone mineral density, P values derived from mixed-effect models for longitudinal percent change from baseline with a fixed effect for treatment groups, time and adjustments for baseline measurements in an intention-to-treat analysis.